Skip to content
Screener

Danaher DHR Western Europe — Sales

Other geography segments

North America
$2.47B+1.5%
High-growth markets
$1.96B+15.4%
Other developed markets
$293M-0.3%

Similar metrics at other companies

Envista Holdings Corporation logo
NVSTWestern Europe — Sales
$165.3M+7.3%
Veralto logo
VLTOWestern Europe — Sales
$338M+9.0%
Astronics logo
ATROEurope — Sales
$38.35M+10.1%
Olin logo
OLNEurope — Sales
$136.9M-7.2%
ATI logo
ATIEurope — Sales
$232.8M-1.3%
Nordson logo
NDSNEurope — Sales
$194.46M+12.7%

Other financials

Income statement

See full
Revenue$6.3B+5.5%
Gross profit$3.6B+2.5%
Operating income$1.1B+48.3%
Net income$870.0M+56.8%
EPS (diluted)$1.23+59.7%

Balance sheet

See full
Cash & equivalents$4.3B+47.0%
Total debt$27.9B+50.1%
Total equity$52.6B+0.5%
Total assets$92.4B+13.2%

Cash flow

See full
Operating cash flow$1.5B+14.6%
CapEx$269.0M+8.5%
Free cash flow$1.3B+16.1%

Valuation

See full
Market cap$140.36B+0.4%
Enterprise value$163.87B+5.5%
P/E35.1×-5.9×
P/S5.6×-0.2×

Profitability

See full
Gross margin58.5%-1.1pp
Operating margin20.4%+2.0pp
Net margin15.9%+1.7pp
FCF margin21.8%+1.5pp

Returns & leverage

See full
Return on equity7.6%+1.0pp
Debt / equity0.5×+0.2×
Current ratio1.7×0.0×

Where this comes from

Reported directly by Danaher in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Danaher’s 10-Q, filed July 21, 2026.

Filed
Jul 20, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000313616-26-000161
For the Three-Month Period Ended June 26, 2026:Biotechnology / For the Three-Month Period Ended June 26, 2026:Life SciencesDiagnosticsTotal
Geographical region:
North America(a)$583$759$1,132$2,474
Western Europe6894214301,540
Other developed markets(b)7412693293
High-growth markets(c)5745738111,958
Total$1,920$1,879$2,466$6,265
Revenue type:
Recurring$1,722$1,268$2,210$5,200

Item 1. Financial Statements

FAQ

What is Danaher's western europe — sales?
Danaher (DHR) reported western europe — sales of $1.54B in Q2 2026.
How has Danaher's western europe — sales changed year-over-year?
Danaher's western europe — sales increased by 2.2% year-over-year, from $1.51B to $1.54B.
What is the long-term trend for Danaher's western europe — sales?
Over 4 years (2021 to 2025), Danaher's western europe — sales has grown at a 0.3% compound annual growth rate (CAGR), from $5.88B to $5.94B.
What does western europe — sales mean?
This metric represents the total revenue generated from products and services sold within the Western European geographic market. It reflects the company's ability to capture market share and drive demand within this specific economic region, serving as a key indicator of regional commercial performance. Fluctuations in this figure often correlate with regional macroeconomic conditions, regulatory environments, and the competitive landscape for scientific and diagnostic solutions.

Ask your AI about Danaher's western europe — sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude